HIV-positive women and cervical screening

International Journal of STD and AIDS

Volumn 11, Issue 12, 2000, Pages 767-773

  Vonau, B ^a   Boag, F ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Cervical screening; CIN; HAART; HIV; HPV

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIGEN DETECTION; ANTIMICROBIAL THERAPY; ARTICLE; CANCER RISK; CANCER SCREENING; DEMOGRAPHY; FEMALE; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS LOAD; WART VIRUS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYOMAVIRIDAE; PREVALENCE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034524954     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462001915192     Document Type: Article

References (58)

1. The invasive potential of carcinoma in situ of the cervix
2. Cervical cancer screening with cervicography and cytology
3. Risk of invasive cervical cancer among women with, or at risk for, HIV infection
4. Spectrum of AiDS-associated malignant disorders
5. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients
6. Characteristics of women with AIDS and invasive cancer
7. Cervical cancer as an AIDS defining illness
8. Is HIV infection a risk factor for advanced cervical cancer?
9. Cervical abnormality and sexually transmitted disease in human immumodeficiency virus-positive women
10. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1
11. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears
12. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women
13. HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers
14. Incidence and progression of cervical squamous lesions among women with HIV: Insights from the first 13,038 Pap smears of the Women's Interagency HIV Study
15. Natural history of cervicovaginal papillomavirus infection in young women
16. High risk of human papillomavirus infection and cervical symptomatic human immunodeficiency virus infection
17. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV
18. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV positive women
19. Human papillomavirus infection in HIV-seropositive women: Natural history and variability of detection
20. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women
21. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression
22. Human papillomavirus infection in human immunodeficiency virus-seropositive women
23. Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners
24. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 RNA plasma level among women with HIV-1 infection
25. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV) positive and high risk HIV negative women
26. Cervical intraepithelial neoplasia
27. Human papillomavirus - The most significant risk determinant of cervical intraepithelial neoplasia
28. Lack of behavioural risk factors for squamous intraepithelial lesions (SIL) in HIV-infected women
29. Risk factors for squamous intraepithelial lesions on Pap smear in women risk of human immunodeficiency virus infection
30. Sexual, contraceptive, and drug use behaviour of women with HW and those at high risk for infection: Results from the Women's Inter-agency HIV Study
31. Colposcopic assessment of the lower genital tract in female renal transplant recipients
32. Human papillomavirus and lower genital neoplasia in renal transplant patients
33. Largerhans cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection
34. Natural history of low grade squamous intraepithelial lesions in women infected with the human immunodeficiency virus
35. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women
36. Cellular immunodeficiency enhances progression of human papillomavirus-associated cervical lesions
37. Prevalence and risk of progression of genital intraepithelial neoplasia in women with human immunodeficiency virus infection
38. Papanicolaou smears in human immunodeficiency virus-seropositive women during follow up
39. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: A prospective study of colposcopy and clinical outcome
40. Laser conization: The results of treatment of cervical intraepithelial neoplasia
41. Cold knife and laser conisation for cervical intraepithelial neoplasia
42. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus
43. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: Outcome after loop electrosurgical excision
44. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus seropositive women
45. Complications after treatment of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus
46. Early regression of cervical lesions in HIV seropositive women receiving highly active antiretroviral therapy
47. Effect of highly active antiretroviral therapy (HAART) on cervical cytologic changes associated with oncogenic HPV among HIV+ women
48. Human immunodeficiency virus type 1 RNA shedding in the female genital tract
49. HIV-1 in the female genital tract and the effect of antiretroviral therapy
50. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract
51. Prevalence, risk factors and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus
52. Clinical significance of mild cytologic atypia on Papanicolaou smears from women infected with human immunodeficiency virus
53. Adequacy of screening cervical cytology among human immunodeficiency virus-seropositive women
54. Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus
55. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV infected women